Savant Capital’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,996
Closed -$14K 1444
2024
Q2
$14K Buy
+11,996
New +$14K ﹤0.01% 1251